Activation Capital, an innovation ecosystem development organization, today announced that it has received $15M in funding from the Commonwealth of Virginia to accelerate the development of Central Virginia’s life sciences sector, including expanding regional capacity for end-to-end essential medicine research, development, and manufacturing.
The new role will oversee strategic initiatives to grow deep-tech entrepreneurship and a regional ecosystem conducive to health and life sciences company formation and scaleup.
The latest funding highlights a series of investments into the Virginia Bio+Tech Park, complementing the City of Richmond’s investment into its Innovation District vision.
The new operations role will help build critical organizational infrastructure to improve performance and achieve strategic goals during a growth phase.
Get updates on all of the programs and activities that Activation Capital supports.
RT @vabio: A big win for VA's life sciences industry! @GovernorVA announced $66.7 M in state grants...
Read MoreRT @HuntonAK_EDCGR: From @RTDNEWS, more great news for the burgeoning pharmaceutical cluster in Cent...
Read MoreRT @allianceformed: Thanks @RichmondInno for the ongoing coverage of our region's innovation ecosyst...
Read MoreGet updates on all of the programs and activities that Activation Capital supports.
Catalyzing tech innovation, company formation, and job creation in Virginia by providing flexible lab spaces, private offices, support services, and educational programming for startups, ESOs and clusters.
Sign Up for Our Newsletter
Copyright © 2023 Activation Capital. All Rights Reserve. Policy and Accessibility.
